MS
Mohinder Singh
About Mohinder Singh
Data last updated:
Mohinder Singh has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Mickle Felix Pharmaceuticals Private Limited and Guru Nanak Biotech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Mickle Felix Pharmaceuticals Private Limited at ₹79,195 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Apr 2021 | 2004 | ₹79,195 (FY 2025) | Active | |
| Director | 15 Dec 2020 | 2020 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohinder Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohinder Singh
Mohinder Singh has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Mickle Felix Pharmaceuticals Private Limited and Guru Nanak Biotech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Mickle Felix Pharmaceuticals Private Limited at ₹79,195 (FY 2025).
Mohinder Singh is associated with 2 companies as Director, including Mickle Felix Pharmaceuticals Private Limited (₹79,195), Guru Nanak Biotech Private Limited.
Mohinder Singh has expertise in General Business, Technology.
Mohinder Singh has 5 years in corporate governance.
By reported revenue, the largest current company of Mohinder Singh is Mickle Felix Pharmaceuticals Private Limited, with revenue of ₹79,195 (FY 2025).
Mohinder Singh currently holds positions at 2 companies: Mickle Felix Pharmaceuticals Private Limited (₹79,195), Guru Nanak Biotech Private Limited.